ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: FR-PO1166

Common Clinical Markers Predict ESRD in Children with Obstructive Uropathy

Session Information

  • Pediatric Nephrology - I
    October 26, 2018 | Location: Exhibit Hall, San Diego Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Pediatric Nephrology

  • 1600 Pediatric Nephrology


  • Mcleod, Daryl J., Nationwide Children's Hospital, Columbus, Ohio, United States
  • Ching, Christina B., Nationwide Children's Hospital, Columbus, Ohio, United States
  • Sebastião, Yuri Vanda, Nationwide Children's Hospital, Columbus, Ohio, United States
  • McHugh, Kirk M., Nationwide Children's Hospital, Columbus, Ohio, United States
  • Becknell, Brian, Nationwide Children's Hospital, Columbus, Ohio, United States

Obstructive uropathy (OU) is the leading cause of pediatric chronic kidney disease (CKD) and end stage renal disease (ESRD). Children who escape the newborn period with mild to moderate CKD continue to be at increased risk for progression, especially as they undergo pubertal changes. The predictive ability of clinical markers throughout childhood is poorly defined in OU.


Patients with OU were identified in the Chronic Kidney Disease in Children Study (CKiD), a prospective observational cohort of children with mild to moderate CKD. The primary outcome of interest was ESRD (Cases). OU patients who did not progress to ESRD during follow-up (Controls) were age matched to Cases. Glomerular Filtration Rate (GFR), urine (protein/Cr and microalbumin/Cr), and serum (CO2, phosphate, albumin, and hemoglobin), were evaluated as predictor variables both at baseline and over time.


Median age at baseline and outcome was 10 vs.16 years(y) respectively. Cases (n=27) and Controls (n=41) had significant differences in baseline GFR (36.9 vs. 53.5 ml/min/1.73m2), urine protein/Cr (0.40 vs. 0.22) and microalbumin/Cr (0.58 vs. 0.03), and serum C02 (20 vs. 22 mmol/L) and hemoglobin (12.4 vs. 13.2 g/dL) respectively. GFR declined 3.07 ml/min/1.73m2/y faster in Cases (p<.0001) (Figure). Urine protein/Cr and microalbumin/Cr declined 0.16/y and 0.11/y faster in Cases respectively (p≤0.001 for both). Serum phosphate increased 0.11 mg/dL/y and albumin and hemoglobin decreased 0.04 g/dL/y and 0.14 g/dL/y faster for Cases respectively (p<0.05 for all).


Baseline and longitudinal evaluation of clinical measures predicts ESRD in children with mild to moderate CKD from OU. Optimal cutoff values require further evaluation so that children identified at high risk can undergo closer surveillance that may allow changes in management to slow or halt progression.

Figure. Estimated change in GFR over time in the CKiD OU cohort